While the idea of using an army of mosquitos to administer vaccines has been considered, we would first need to find a vaccine for malaria.
Read more
Sending a spacecraft to the far reaches of our solar system to mine asteroids might seem like an improbable ambition best left to science fiction. But it’s inching closer to reality. A NASA mission is underway to test the feasibility on a nearby asteroid, and a niche group of companies is ramping up to claim a piece of the pie.
Industry barons see a future in finding and harnessing water on asteroids for rocket fuel, which will allow astronauts and spacecrafts to stay in orbit for longer periods. Investors, including Richard Branson, China’s Tencent Holdings and the nation of Luxembourg, see a longer-term solution to replenishing materials such as iron and nickel as Earth’s natural resources are depleted.
Millions of asteroids roam our solar system. Most are thought unsuitable for mining, either because they’re too small, too inaccessible to Earth or because the materials that make up the asteroid have little value. But we know of almost 1,000 asteroids that show potential. Timing is everything, though. The varied orbits of these asteroids mean that many are nearby only once every several years.
Read more
Researchers at Harvard have described a new cancer vaccine approach that uses an injectable biomaterial scaffold to deliver a payload of tumor-specific peptides that stimulate the immune system to respond rapidly to cancer cells.
Abstract
Existing strategies to enhance peptide immunogenicity for cancer vaccination generally require direct peptide alteration, which, beyond practical issues, may impact peptide presentation and result in vaccine variability. Here, we report a simple adsorption approach using polyethyleneimine (PEI) in a mesoporous silica microrod (MSR) vaccine to enhance antigen immunogenicity. The MSR–PEI vaccine significantly enhanced host dendritic cell activation and T-cell response over the existing MSR vaccine and bolus vaccine formulations. Impressively, a single injection of the MSR–PEI vaccine using an E7 peptide completely eradicated large, established TC-1 tumours in about 80% of mice and generated immunological memory. When immunized with a pool of B16F10 or CT26 neoantigens, the MSR–PEI vaccine eradicated established lung metastases, controlled tumour growth and synergized with anti-CTLA4 therapy.
Read more
Neutron stars aren’t the twinkle-twinkle kind you typically see in the night sky. They’re stellar corpses, and incredibly dense sources of gravity, with perhaps 1.5 times the mass of the sun packed into an area less than a dozen miles across. Around 9,000 light years away from Earth, one neutron star seems to have befriended a red dwarf. And scientists observed the new relationship beginning in a flash of energy.
An international team of researchers first spotted what looked like the symbiotic relationship of an old red dwarf star waking up a neutron star on August 13, 2017, using an Earth-orbiting telescope called INTEGRAL. While binary stars are common, lots of things about this finding, from capturing the initial blast that signaled the start of the stellar relationship, were a surprise.
“It was a very exciting find,” study author Arash Bahramian from Michigan State University told Gizmodo, “Especially given that it’s rare to see the start of the process.”
Read more
We are making good progress in identifying neural circuits in our brain, small areas responsible for the execution of specific tasks. It is not always the case, actually several tasks are involving many areas in different regions of the brain. Also in this case, however, specific regions host neural circuits whose activity spread around influencing other neural networks. The malfunctioning of these “networks” results in disabilities and the good news is that researchers are starting to find ways to restore (in some cases) the correct working of these neural circuits using drugs.
The problem, however, is that these drugs cannot be delivered through the blood vessels since they would reach “the whole brain” and what is good for a “faulty” circuit may be bad for a “good” circuit. Besides, many drugs cannot flow across the membrane separating the arteries and veins from the brain (the so called blood-brain barrier). This obstacle is exploited by new technologies based on ultrasound beams that can be focussed in a specific place of the brain resulting in the opening of the blood vessels membrane in that area thus letting the drug reach the neurones. This is great but in mot cases it is not enough because the area “flooded” by the drug is still quite large (on a neuronal scale).
Here comes the result from researchers at MIT that have created a way to deliver nanoliter of drugs to areas as small as a cubic millimetre. Again, on the neural scale a cubic millimetre is … well, huge: it contains some 50,000 neurones and 300 million synapses! It is anyhow so much smaller than the area that would be affected by a drug delivered through a blood vessel (even the one that creates a breach into the blood brain barrier), hence it can target much better the faulty circuit without too much effects on other nearby circuits.
Read more
The vast majority of Americans expect artificial intelligence to lead to job losses in the coming decade, but few see it coming for their own position.
The other findings, released in January, show that more than three in four Americans believe that artificial intelligence will fundamentally change how the public works and lives in the coming decade.
A new study reveals how widely Americans use and welcome technologies featuring artificial intelligence.
Read more